These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 18321157)

  • 1. Treatment perspectives for the lysosomal storage diseases.
    Grabowski GA
    Expert Opin Emerg Drugs; 2008 Mar; 13(1):197-211. PubMed ID: 18321157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current and emerging therapies for the lysosomal storage disorders.
    Pastores GM; Barnett NL
    Expert Opin Emerg Drugs; 2005 Nov; 10(4):891-902. PubMed ID: 16262569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gaucher disease and other storage disorders.
    Grabowski GA
    Hematology Am Soc Hematol Educ Program; 2012; 2012():13-8. PubMed ID: 23233555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy for lysosomal storage disorders.
    Beck M
    IUBMB Life; 2010 Jan; 62(1):33-40. PubMed ID: 20014233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination Therapies for Lysosomal Storage Diseases: A Complex Answer to a Simple Problem.
    Macauley SL
    Pediatr Endocrinol Rev; 2016 Jun; 13 Suppl 1(Suppl 1):639-48. PubMed ID: 27491211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lysosomes and lysosomal storage diseases].
    Germain DP
    J Soc Biol; 2002; 196(2):127-34. PubMed ID: 12360741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDA orphan drug designations for lysosomal storage disorders - a cross-sectional analysis.
    Garbade SF; Zielonka M; Mechler K; Kölker S; Hoffmann GF; Staufner C; Mengel E; Ries M
    PLoS One; 2020; 15(4):e0230898. PubMed ID: 32267884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Less Is More: Substrate Reduction Therapy for Lysosomal Storage Disorders.
    Coutinho MF; Santos JI; Alves S
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27384562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined Therapies for Lysosomal Storage Diseases.
    Gabig-Cimińska M; Jakóbkiewicz-Banecka J; Malinowska M; Kloska A; Piotrowska E; Chmielarz I; Moskot M; Węgrzyn A; Węgrzyn G
    Curr Mol Med; 2015; 15(8):746-71. PubMed ID: 26391547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in treatment approaches of lysosomal storage diseases (LSDs).
    Rozenfeld PA
    Curr Pharm Biotechnol; 2011 Jun; 12(6):853. PubMed ID: 21506916
    [No Abstract]   [Full Text] [Related]  

  • 11. New strategies for the treatment of lysosomal storage diseases (review).
    Parenti G; Pignata C; Vajro P; Salerno M
    Int J Mol Med; 2013 Jan; 31(1):11-20. PubMed ID: 23165354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatments for lysosomal storage disorders.
    Lachmann R
    Biochem Soc Trans; 2010 Dec; 38(6):1465-8. PubMed ID: 21118108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Comparative Study on the Alterations of Endocytic Pathways in Multiple Lysosomal Storage Disorders.
    Rappaport J; Manthe RL; Solomon M; Garnacho C; Muro S
    Mol Pharm; 2016 Feb; 13(2):357-368. PubMed ID: 26702793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysosomal Storage Disorders: Molecular Basis and Therapeutic Approaches.
    Moro E
    Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34208892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substrate reduction therapy for lysosomal storage diseases.
    Cox TM
    Acta Paediatr Suppl; 2005 Mar; 94(447):69-75; discussion 57. PubMed ID: 15895716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment options for lysosomal storage disorders: developing insights.
    van Gelder CM; Vollebregt AA; Plug I; van der Ploeg AT; Reuser AJ
    Expert Opin Pharmacother; 2012 Nov; 13(16):2281-99. PubMed ID: 23009070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme replacement therapy and beyond-in memoriam Roscoe O. Brady, M.D. (1923-2016).
    Ries M
    J Inherit Metab Dis; 2017 May; 40(3):343-356. PubMed ID: 28314976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy for lysosomal storage disorders.
    Barranger JM; Novelli EA
    Expert Opin Biol Ther; 2001 Sep; 1(5):857-67. PubMed ID: 11728220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PATIENT-REPORTED OUTCOMES IN RARE LYSOSOMAL STORAGE DISEASES: KEY INFORMANT INTERVIEWS AND A SYSTEMATIC REVIEW PROTOCOL.
    Miller PA; Mulla SM; Adams-Webber T; Sivji Y; Guyatt GH; Johnston BC
    Int J Technol Assess Health Care; 2016 Jan; 32(6):393-399. PubMed ID: 28029334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurological manifestations in lysosomal storage disorders - from pathology to first therapeutic possibilities.
    Hoffmann B; Mayatepek E
    Neuropediatrics; 2005 Oct; 36(5):285-9. PubMed ID: 16217702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.